Literature DB >> 16230198

Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem.

Shio-Shin Jean1, Yu-Tsang Lee, Su-Mei Guo, Po-Ren Hsueh.   

Abstract

We present a case of recurrent infection (infective spondilitis, psoas abscess, and bacteraemia) caused by a single strain of cefotaxime- and ciprofloxacin-resistant and bla(CMY-2)-containing Salmonella enterica serotype choleraesuis during a 4-month period in a patient with uremia. The patient was successfully treated with imipenem for 7 weeks. Our observation indicates that a carbapenem might be considered as a drug of choice for the treatment of infections caused by this emerging multi-resistant pathogen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230198     DOI: 10.1016/j.jinf.2004.12.011

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Bacteraemia due to ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis in adult patients at a university hospital in Taiwan, 1996-2004.

Authors:  J-Y Wang; J-J Hwang; C-N Hsu; L-C Lin; P-R Hsueh
Journal:  Epidemiol Infect       Date:  2006-03-29       Impact factor: 2.451

2.  Osteomyelitis, discitis, epidural and psoas abscess secondary to Salmonella enterica in a man with diabetes mellitus and newly diagnosed α-thalassaemia trait.

Authors:  Helen Farrar; Aoife Abbey; Vinod Patel; Rajiv Nair
Journal:  BMJ Case Rep       Date:  2015-01-21

3.  Infectious Aortitis: A Life-Threatening Endovascular Complication of Nontyphoidal Salmonella Bacteremia.

Authors:  Seifeldin Hakim; Francisco Davila; Mitual Amin; Ismail Hader; Mitchell S Cappell
Journal:  Case Rep Med       Date:  2018-04-01

4.  A case of multidrug-resistant Salmonella enterica serovar Typhi treated with a bench to bedside approach.

Authors:  Hee Jung Yoon; Soung Hoon Cho; Seong Han Kim
Journal:  Yonsei Med J       Date:  2009-02-24       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.